临床使用达菲,医生一定要注意这3点

2018-01-13 朱晓萍 上海东方医院

当患者缺乏病原学诊断证据时,医生如何才能清晰界定达菲的使用指征,在避免滥用、错用的前提下,达到改善患者预后的效果?

在重症流感和重症流感病毒性肺炎的救治过程中,往往存在病情快速发展与等待病原学诊断结果的矛盾。

当患者缺乏病原学诊断证据时,医生如何才能清晰界定达菲的使用指征,在避免滥用、错用的前提下,达到改善患者预后的效果?

同济大学附属东方医院本部呼吸科主任朱晓萍,建议以下三种情况下医生可以向患者开具达菲:

首先,明确重症流感高危人群的定义:

年龄<5岁的儿童

年龄≥65岁的老年人;

伴有以下疾病或状况者:慢性呼吸系统疾病、心血管系统疾病(高血压除外)、肾病、肝病、血液系统疾病、神经系统及神经肌肉疾病、代谢及内分泌系统疾病、免疫功能抑制(包括应用免疫抑制剂或HIV感染等致免疫功能低下);

肥胖者[体重指数(body mass index,BMI)大于30,BMI=体重(kg)/身高(m)2];

妊娠期妇女。

一.对于重症流感高危人群,出现流感样症状包括:发热、头痛、肌痛、全身不适、咽喉痛、干咳、鼻塞、流涕、胸骨后不适、颜面潮红、眼结膜充血、部分表现呕吐、腹痛、腹泻等,程度偏重者,建议尽早(发病48h内)使用达菲。

二.重症流感患者可能有并发症者:

1.持续高热>3天,伴有剧烈咳嗽,咳脓痰、血痰,或胸痛;

2.合并肺炎;

3.   呼吸频率快,呼吸困难,口唇紫绀;

4.神志改变:反应迟钝、嗜睡、躁动、惊厥等

5.严重呕吐、腹泻,出现脱水表现;

6.原有基础疾病明显加重。

重症流感患者符合以上6条中一项者,应尽早给予抗流感病毒(达菲,剂量甚至加倍)治疗,不必等待病毒检测结果;如果发病时间超过48 h,症状无改善或呈恶化倾向时也应进行抗流感病毒如达菲治疗。

三、无重症流感高危因素的患者,症状偏重者发病时间不足48 h,为缩短病程、减少并发症也可以抗病毒使用达菲治疗,但必须经专家评估。无高危因素且无并发症者病程多呈自限性。

“达菲”在临床被广泛使用,所以出现耐药性病毒的报告。

达菲主要的不良反应:

消化道:恶心、呕吐、腹泻、腹痛等;

其次是呼吸系统的不良反应,包括支气管炎、咳嗽等;

此外还有中枢神经系统的不良反应,如眩晕、头痛、失眠、疲劳等。

另外日本有报道服用达菲后出现青少年的精神异常,因此,一定避免滥用达菲。

作者简介

朱晓萍,荷兰Nijmegen大学医学博士、同济大学附属东方医院本部呼吸内科主任、主任医师、博士生导师。

美国胸科协会会员,上海医师协会呼吸分会委员,中华肺部疾病杂志和上海医药杂志编委,国家自然基金项目评议人。

以第一和通讯作者发表SCI论着6篇(AJP和JAP等),获得国家自然基金和上海市科委自然基金等六项课题,获上海市浦东新区科技进步二等奖和浦东新区工会科技创新三等奖。

三甲教学医院呼吸内科专业近30年。专业擅长:肺结节的影像学判读,肺癌早期诊断及规范化治疗,肺栓塞及肺部疑难疾病的诊断及鉴别诊断。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1689924, encodeId=2efd16899249b, content=<a href='/topic/show?id=c5f2226e9d3' target=_blank style='color:#2F92EE;'>#临床使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22679, encryptionId=c5f2226e9d3, topicName=临床使用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=703d28925250, createdName=12498e87m48暂无昵称, createdTime=Fri Sep 07 20:56:00 CST 2018, time=2018-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284741, encodeId=b76e284e412e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221028/11610bd349304a3a86a2c437d4cf0b47/30aeaebb323a43c193abde39a65e8ce0.jpg, createdBy=957a2221566, createdName=15991890016白熊, createdTime=Sat Feb 03 11:54:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281148, encodeId=78d82811486d, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Jan 23 06:58:43 CST 2018, time=2018-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278393, encodeId=93032e839319, content=很有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Sun Jan 14 10:39:12 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278389, encodeId=ce682e83896f, content=在重症流感和重症流感病毒性肺炎的救治过程中.往往存在病情快速发展与等待病原学诊断结果的矛盾, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUlbw1Mf1vppicGcaWPx1YUOgLgKccao77Rykbx3jiazqzwcyXMdzRIZkhFyBPqknibeuOGhXI1VzVg/0, createdBy=7f162154630, createdName=沙漠浪人, createdTime=Sun Jan 14 10:22:40 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278379, encodeId=a7712e837997, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Sun Jan 14 09:30:14 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278371, encodeId=7f642e8371bd, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6512108074, createdName=1581f80970m, createdTime=Sun Jan 14 09:18:34 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278351, encodeId=487c2e835184, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jan 14 08:41:04 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278330, encodeId=041d2e833060, content=不错不错.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/31/a88428e95e462b5a95499ced50b4325e.jpg, createdBy=60182225250, createdName=15121100f4m, createdTime=Sun Jan 14 08:04:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278257, encodeId=ff5c2e8257a3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Jan 13 23:49:02 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1689924, encodeId=2efd16899249b, content=<a href='/topic/show?id=c5f2226e9d3' target=_blank style='color:#2F92EE;'>#临床使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22679, encryptionId=c5f2226e9d3, topicName=临床使用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=703d28925250, createdName=12498e87m48暂无昵称, createdTime=Fri Sep 07 20:56:00 CST 2018, time=2018-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284741, encodeId=b76e284e412e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221028/11610bd349304a3a86a2c437d4cf0b47/30aeaebb323a43c193abde39a65e8ce0.jpg, createdBy=957a2221566, createdName=15991890016白熊, createdTime=Sat Feb 03 11:54:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281148, encodeId=78d82811486d, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Jan 23 06:58:43 CST 2018, time=2018-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278393, encodeId=93032e839319, content=很有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Sun Jan 14 10:39:12 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278389, encodeId=ce682e83896f, content=在重症流感和重症流感病毒性肺炎的救治过程中.往往存在病情快速发展与等待病原学诊断结果的矛盾, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUlbw1Mf1vppicGcaWPx1YUOgLgKccao77Rykbx3jiazqzwcyXMdzRIZkhFyBPqknibeuOGhXI1VzVg/0, createdBy=7f162154630, createdName=沙漠浪人, createdTime=Sun Jan 14 10:22:40 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278379, encodeId=a7712e837997, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Sun Jan 14 09:30:14 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278371, encodeId=7f642e8371bd, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6512108074, createdName=1581f80970m, createdTime=Sun Jan 14 09:18:34 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278351, encodeId=487c2e835184, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jan 14 08:41:04 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278330, encodeId=041d2e833060, content=不错不错.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/31/a88428e95e462b5a95499ced50b4325e.jpg, createdBy=60182225250, createdName=15121100f4m, createdTime=Sun Jan 14 08:04:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278257, encodeId=ff5c2e8257a3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Jan 13 23:49:02 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
    2018-02-03 15991890016白熊

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1689924, encodeId=2efd16899249b, content=<a href='/topic/show?id=c5f2226e9d3' target=_blank style='color:#2F92EE;'>#临床使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22679, encryptionId=c5f2226e9d3, topicName=临床使用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=703d28925250, createdName=12498e87m48暂无昵称, createdTime=Fri Sep 07 20:56:00 CST 2018, time=2018-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284741, encodeId=b76e284e412e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221028/11610bd349304a3a86a2c437d4cf0b47/30aeaebb323a43c193abde39a65e8ce0.jpg, createdBy=957a2221566, createdName=15991890016白熊, createdTime=Sat Feb 03 11:54:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281148, encodeId=78d82811486d, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Jan 23 06:58:43 CST 2018, time=2018-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278393, encodeId=93032e839319, content=很有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Sun Jan 14 10:39:12 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278389, encodeId=ce682e83896f, content=在重症流感和重症流感病毒性肺炎的救治过程中.往往存在病情快速发展与等待病原学诊断结果的矛盾, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUlbw1Mf1vppicGcaWPx1YUOgLgKccao77Rykbx3jiazqzwcyXMdzRIZkhFyBPqknibeuOGhXI1VzVg/0, createdBy=7f162154630, createdName=沙漠浪人, createdTime=Sun Jan 14 10:22:40 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278379, encodeId=a7712e837997, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Sun Jan 14 09:30:14 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278371, encodeId=7f642e8371bd, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6512108074, createdName=1581f80970m, createdTime=Sun Jan 14 09:18:34 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278351, encodeId=487c2e835184, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jan 14 08:41:04 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278330, encodeId=041d2e833060, content=不错不错.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/31/a88428e95e462b5a95499ced50b4325e.jpg, createdBy=60182225250, createdName=15121100f4m, createdTime=Sun Jan 14 08:04:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278257, encodeId=ff5c2e8257a3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Jan 13 23:49:02 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
    2018-01-23 1209e435m98(暂无昵称)

    学习了.谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1689924, encodeId=2efd16899249b, content=<a href='/topic/show?id=c5f2226e9d3' target=_blank style='color:#2F92EE;'>#临床使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22679, encryptionId=c5f2226e9d3, topicName=临床使用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=703d28925250, createdName=12498e87m48暂无昵称, createdTime=Fri Sep 07 20:56:00 CST 2018, time=2018-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284741, encodeId=b76e284e412e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221028/11610bd349304a3a86a2c437d4cf0b47/30aeaebb323a43c193abde39a65e8ce0.jpg, createdBy=957a2221566, createdName=15991890016白熊, createdTime=Sat Feb 03 11:54:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281148, encodeId=78d82811486d, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Jan 23 06:58:43 CST 2018, time=2018-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278393, encodeId=93032e839319, content=很有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Sun Jan 14 10:39:12 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278389, encodeId=ce682e83896f, content=在重症流感和重症流感病毒性肺炎的救治过程中.往往存在病情快速发展与等待病原学诊断结果的矛盾, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUlbw1Mf1vppicGcaWPx1YUOgLgKccao77Rykbx3jiazqzwcyXMdzRIZkhFyBPqknibeuOGhXI1VzVg/0, createdBy=7f162154630, createdName=沙漠浪人, createdTime=Sun Jan 14 10:22:40 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278379, encodeId=a7712e837997, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Sun Jan 14 09:30:14 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278371, encodeId=7f642e8371bd, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6512108074, createdName=1581f80970m, createdTime=Sun Jan 14 09:18:34 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278351, encodeId=487c2e835184, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jan 14 08:41:04 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278330, encodeId=041d2e833060, content=不错不错.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/31/a88428e95e462b5a95499ced50b4325e.jpg, createdBy=60182225250, createdName=15121100f4m, createdTime=Sun Jan 14 08:04:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278257, encodeId=ff5c2e8257a3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Jan 13 23:49:02 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
    2018-01-14 小不忍则

    很有用!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1689924, encodeId=2efd16899249b, content=<a href='/topic/show?id=c5f2226e9d3' target=_blank style='color:#2F92EE;'>#临床使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22679, encryptionId=c5f2226e9d3, topicName=临床使用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=703d28925250, createdName=12498e87m48暂无昵称, createdTime=Fri Sep 07 20:56:00 CST 2018, time=2018-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284741, encodeId=b76e284e412e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221028/11610bd349304a3a86a2c437d4cf0b47/30aeaebb323a43c193abde39a65e8ce0.jpg, createdBy=957a2221566, createdName=15991890016白熊, createdTime=Sat Feb 03 11:54:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281148, encodeId=78d82811486d, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Jan 23 06:58:43 CST 2018, time=2018-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278393, encodeId=93032e839319, content=很有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Sun Jan 14 10:39:12 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278389, encodeId=ce682e83896f, content=在重症流感和重症流感病毒性肺炎的救治过程中.往往存在病情快速发展与等待病原学诊断结果的矛盾, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUlbw1Mf1vppicGcaWPx1YUOgLgKccao77Rykbx3jiazqzwcyXMdzRIZkhFyBPqknibeuOGhXI1VzVg/0, createdBy=7f162154630, createdName=沙漠浪人, createdTime=Sun Jan 14 10:22:40 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278379, encodeId=a7712e837997, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Sun Jan 14 09:30:14 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278371, encodeId=7f642e8371bd, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6512108074, createdName=1581f80970m, createdTime=Sun Jan 14 09:18:34 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278351, encodeId=487c2e835184, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jan 14 08:41:04 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278330, encodeId=041d2e833060, content=不错不错.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/31/a88428e95e462b5a95499ced50b4325e.jpg, createdBy=60182225250, createdName=15121100f4m, createdTime=Sun Jan 14 08:04:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278257, encodeId=ff5c2e8257a3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Jan 13 23:49:02 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
    2018-01-14 沙漠浪人

    在重症流感和重症流感病毒性肺炎的救治过程中.往往存在病情快速发展与等待病原学诊断结果的矛盾

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1689924, encodeId=2efd16899249b, content=<a href='/topic/show?id=c5f2226e9d3' target=_blank style='color:#2F92EE;'>#临床使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22679, encryptionId=c5f2226e9d3, topicName=临床使用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=703d28925250, createdName=12498e87m48暂无昵称, createdTime=Fri Sep 07 20:56:00 CST 2018, time=2018-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284741, encodeId=b76e284e412e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221028/11610bd349304a3a86a2c437d4cf0b47/30aeaebb323a43c193abde39a65e8ce0.jpg, createdBy=957a2221566, createdName=15991890016白熊, createdTime=Sat Feb 03 11:54:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281148, encodeId=78d82811486d, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Jan 23 06:58:43 CST 2018, time=2018-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278393, encodeId=93032e839319, content=很有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Sun Jan 14 10:39:12 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278389, encodeId=ce682e83896f, content=在重症流感和重症流感病毒性肺炎的救治过程中.往往存在病情快速发展与等待病原学诊断结果的矛盾, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUlbw1Mf1vppicGcaWPx1YUOgLgKccao77Rykbx3jiazqzwcyXMdzRIZkhFyBPqknibeuOGhXI1VzVg/0, createdBy=7f162154630, createdName=沙漠浪人, createdTime=Sun Jan 14 10:22:40 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278379, encodeId=a7712e837997, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Sun Jan 14 09:30:14 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278371, encodeId=7f642e8371bd, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6512108074, createdName=1581f80970m, createdTime=Sun Jan 14 09:18:34 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278351, encodeId=487c2e835184, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jan 14 08:41:04 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278330, encodeId=041d2e833060, content=不错不错.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/31/a88428e95e462b5a95499ced50b4325e.jpg, createdBy=60182225250, createdName=15121100f4m, createdTime=Sun Jan 14 08:04:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278257, encodeId=ff5c2e8257a3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Jan 13 23:49:02 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
    2018-01-14 183****7028

    学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1689924, encodeId=2efd16899249b, content=<a href='/topic/show?id=c5f2226e9d3' target=_blank style='color:#2F92EE;'>#临床使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22679, encryptionId=c5f2226e9d3, topicName=临床使用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=703d28925250, createdName=12498e87m48暂无昵称, createdTime=Fri Sep 07 20:56:00 CST 2018, time=2018-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284741, encodeId=b76e284e412e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221028/11610bd349304a3a86a2c437d4cf0b47/30aeaebb323a43c193abde39a65e8ce0.jpg, createdBy=957a2221566, createdName=15991890016白熊, createdTime=Sat Feb 03 11:54:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281148, encodeId=78d82811486d, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Jan 23 06:58:43 CST 2018, time=2018-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278393, encodeId=93032e839319, content=很有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Sun Jan 14 10:39:12 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278389, encodeId=ce682e83896f, content=在重症流感和重症流感病毒性肺炎的救治过程中.往往存在病情快速发展与等待病原学诊断结果的矛盾, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUlbw1Mf1vppicGcaWPx1YUOgLgKccao77Rykbx3jiazqzwcyXMdzRIZkhFyBPqknibeuOGhXI1VzVg/0, createdBy=7f162154630, createdName=沙漠浪人, createdTime=Sun Jan 14 10:22:40 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278379, encodeId=a7712e837997, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Sun Jan 14 09:30:14 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278371, encodeId=7f642e8371bd, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6512108074, createdName=1581f80970m, createdTime=Sun Jan 14 09:18:34 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278351, encodeId=487c2e835184, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jan 14 08:41:04 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278330, encodeId=041d2e833060, content=不错不错.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/31/a88428e95e462b5a95499ced50b4325e.jpg, createdBy=60182225250, createdName=15121100f4m, createdTime=Sun Jan 14 08:04:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278257, encodeId=ff5c2e8257a3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Jan 13 23:49:02 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
    2018-01-14 1581f80970m

    学习了.谢谢分享

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1689924, encodeId=2efd16899249b, content=<a href='/topic/show?id=c5f2226e9d3' target=_blank style='color:#2F92EE;'>#临床使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22679, encryptionId=c5f2226e9d3, topicName=临床使用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=703d28925250, createdName=12498e87m48暂无昵称, createdTime=Fri Sep 07 20:56:00 CST 2018, time=2018-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284741, encodeId=b76e284e412e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221028/11610bd349304a3a86a2c437d4cf0b47/30aeaebb323a43c193abde39a65e8ce0.jpg, createdBy=957a2221566, createdName=15991890016白熊, createdTime=Sat Feb 03 11:54:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281148, encodeId=78d82811486d, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Jan 23 06:58:43 CST 2018, time=2018-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278393, encodeId=93032e839319, content=很有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Sun Jan 14 10:39:12 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278389, encodeId=ce682e83896f, content=在重症流感和重症流感病毒性肺炎的救治过程中.往往存在病情快速发展与等待病原学诊断结果的矛盾, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUlbw1Mf1vppicGcaWPx1YUOgLgKccao77Rykbx3jiazqzwcyXMdzRIZkhFyBPqknibeuOGhXI1VzVg/0, createdBy=7f162154630, createdName=沙漠浪人, createdTime=Sun Jan 14 10:22:40 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278379, encodeId=a7712e837997, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Sun Jan 14 09:30:14 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278371, encodeId=7f642e8371bd, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6512108074, createdName=1581f80970m, createdTime=Sun Jan 14 09:18:34 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278351, encodeId=487c2e835184, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jan 14 08:41:04 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278330, encodeId=041d2e833060, content=不错不错.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/31/a88428e95e462b5a95499ced50b4325e.jpg, createdBy=60182225250, createdName=15121100f4m, createdTime=Sun Jan 14 08:04:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278257, encodeId=ff5c2e8257a3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Jan 13 23:49:02 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
    2018-01-14 1dd8c52fm63(暂无匿称)

    了解了解.学习学习

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1689924, encodeId=2efd16899249b, content=<a href='/topic/show?id=c5f2226e9d3' target=_blank style='color:#2F92EE;'>#临床使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22679, encryptionId=c5f2226e9d3, topicName=临床使用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=703d28925250, createdName=12498e87m48暂无昵称, createdTime=Fri Sep 07 20:56:00 CST 2018, time=2018-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284741, encodeId=b76e284e412e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221028/11610bd349304a3a86a2c437d4cf0b47/30aeaebb323a43c193abde39a65e8ce0.jpg, createdBy=957a2221566, createdName=15991890016白熊, createdTime=Sat Feb 03 11:54:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281148, encodeId=78d82811486d, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Jan 23 06:58:43 CST 2018, time=2018-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278393, encodeId=93032e839319, content=很有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Sun Jan 14 10:39:12 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278389, encodeId=ce682e83896f, content=在重症流感和重症流感病毒性肺炎的救治过程中.往往存在病情快速发展与等待病原学诊断结果的矛盾, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUlbw1Mf1vppicGcaWPx1YUOgLgKccao77Rykbx3jiazqzwcyXMdzRIZkhFyBPqknibeuOGhXI1VzVg/0, createdBy=7f162154630, createdName=沙漠浪人, createdTime=Sun Jan 14 10:22:40 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278379, encodeId=a7712e837997, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Sun Jan 14 09:30:14 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278371, encodeId=7f642e8371bd, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6512108074, createdName=1581f80970m, createdTime=Sun Jan 14 09:18:34 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278351, encodeId=487c2e835184, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jan 14 08:41:04 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278330, encodeId=041d2e833060, content=不错不错.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/31/a88428e95e462b5a95499ced50b4325e.jpg, createdBy=60182225250, createdName=15121100f4m, createdTime=Sun Jan 14 08:04:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278257, encodeId=ff5c2e8257a3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Jan 13 23:49:02 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
    2018-01-14 15121100f4m

    不错不错.谢谢分享

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1689924, encodeId=2efd16899249b, content=<a href='/topic/show?id=c5f2226e9d3' target=_blank style='color:#2F92EE;'>#临床使用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22679, encryptionId=c5f2226e9d3, topicName=临床使用)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=703d28925250, createdName=12498e87m48暂无昵称, createdTime=Fri Sep 07 20:56:00 CST 2018, time=2018-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=284741, encodeId=b76e284e412e, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221028/11610bd349304a3a86a2c437d4cf0b47/30aeaebb323a43c193abde39a65e8ce0.jpg, createdBy=957a2221566, createdName=15991890016白熊, createdTime=Sat Feb 03 11:54:00 CST 2018, time=2018-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=281148, encodeId=78d82811486d, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Jan 23 06:58:43 CST 2018, time=2018-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278393, encodeId=93032e839319, content=很有用!, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/31/c5cd65bc1b2b43a9370a16b370993572.jpg, createdBy=baa92155751, createdName=小不忍则, createdTime=Sun Jan 14 10:39:12 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278389, encodeId=ce682e83896f, content=在重症流感和重症流感病毒性肺炎的救治过程中.往往存在病情快速发展与等待病原学诊断结果的矛盾, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUlbw1Mf1vppicGcaWPx1YUOgLgKccao77Rykbx3jiazqzwcyXMdzRIZkhFyBPqknibeuOGhXI1VzVg/0, createdBy=7f162154630, createdName=沙漠浪人, createdTime=Sun Jan 14 10:22:40 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278379, encodeId=a7712e837997, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/iaAVWEsIJUkA1ITy3uL0lhHUhyaJibWgFtH4KbJuaLbY2WUK33jgCFyoZ8Eqx7eE7hCuZhytc1C5GRrfjVXN8lYg/0, createdBy=fcb82149579, createdName=183****7028, createdTime=Sun Jan 14 09:30:14 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278371, encodeId=7f642e8371bd, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6512108074, createdName=1581f80970m, createdTime=Sun Jan 14 09:18:34 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278351, encodeId=487c2e835184, content=了解了解.学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Jan 14 08:41:04 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278330, encodeId=041d2e833060, content=不错不错.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/31/a88428e95e462b5a95499ced50b4325e.jpg, createdBy=60182225250, createdName=15121100f4m, createdTime=Sun Jan 14 08:04:07 CST 2018, time=2018-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278257, encodeId=ff5c2e8257a3, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Sat Jan 13 23:49:02 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
    2018-01-13 戒馋,懒,贪

    谢谢分享学习了

    0

相关资讯

世卫组织称有足够证据证明达菲可阻止流感恶化

  英国著名医学期刊声称,没有证据显示抗流感药物"达菲"有防治流感的作用,该期刊要求瑞士制药公司罗氏公布与达菲相关的所有数据。   与《英国医学杂志》(British Medical Journal)有关联的一名研究员格茨彻(Peter Gotzsche),昨天呼吁欧洲各国政府起诉瑞士罗氏药剂公司(Roche)。他说,各国政府应该向罗氏采取法律行动,以便拿回因囤积达菲而花费的"不必要的"金钱。

BMJ:双倍剂量达菲治疗重症流感或无优势

  一项来自东南亚的研究表明,使用双倍剂量的奥司他韦(达菲)治疗重症流感住院患者,与标准剂量相比,并无病毒学或临床优势。该研究结果2013年5月30日在线发表于BMJ。   该研究在2007年4月到2010年2月期间,纳入326名重症流感患者(主要是15岁以下的儿童),将其分为两组,一组接受标准剂量(75mg,一日两次,儿童剂量当量),另外一组接受双倍剂量(150mg,一日两次,儿童剂量当量)的

学者就“达菲到底治不治病”展开大讨论

  各国政府在抗病毒药物达菲上投入数十亿美元,以保护自己的国民免受流感的侵袭。这是在浪费金钱吗?   各国政府在抗病毒药物达菲(也称为奥司他韦)上投入数十亿美元,以保护自己的国民免受流感的侵袭。这是在浪费金钱吗?经过多年研究,一个国际研究小组表示,答案可能是肯定的。   各执一词   在国际循证医学协作组(Cochrane Collaboration

达菲被指实际无效,罗氏或隐瞒关键信息

4月10日,BBC援引科克伦协作组织的研究报告称,禽流感特效药“达菲”并不能阻止禽流感传播和缓解病症,只能略微有助于疾病康复。而英国已经在这一药品上花费了4.73亿英镑。科克伦协作组织是一家利用循证的方法进行健康系统评价的全球性组织。达菲通用名为磷酸奥司他韦,是目前公认的治疗禽流感一线用药。国内非典、H1N1、H7N9等防治手册中,均把达菲列为主要治疗药品。然而关于达菲的警示也层出不穷,2012年

Nature:达菲已成战略储备资源?

近日,一群来自非营利组织的医学专家在分析了此前未发表过的临床试验结果后称,各国政府已在储备用于治疗季节性和流行性感冒的抗病毒药物上浪费了数十亿美元。 4年多来,总部位于英国牛津的国际循证医学协作组一直就抗病毒药物达菲的功效不断提出异议。起初,该组织只是针对可利用的、有限的公开数据进行分析。如今,通过和《英国医学杂志》合作获取到未发表的达菲临床试验全部数据,国际循证医学协作组发表了一份长达500

FDA批准达菲治疗初现流感症状的婴幼儿

     FDA于12月21日批准扩大罗氏公司抗流感药物达菲的适用症,允许在出现流感症状不超过两天的两周龄儿童中使用达菲。FDA称,该药不能用来预防该年龄组的流感感染。达菲目前被批准在一岁及以上儿童中治疗和预防流感,能够帮助减轻病情并缩短病程。达菲于1999年获批,由基因泰克负责美国地区销售。最常见的副作用为呕吐和腹泻。FDA称,该扩大适应症是基于成人和大龄儿童的试验数据的推测以及美国国立